array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "ROCHE DIAGNOSTICS LIMITED"
["slug"]=>
string(34) "ef866-gb-roche-diagnostics-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c"
["description"]=>
string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation"
["address_street"]=>
string(14) "Charles Avenue"
["address_place"]=>
string(12) "BURGESS HILL"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1956-09-14"
["website_domain"]=>
string(9) "roche.com"
["website_url"]=>
string(29) "https://diagnostics.roche.com"
["industry_codes"]=>
array(1) {
[0]=>
string(43) "Business Services, Not Elsewhere Classified"
}
["employee_count"]=>
int(658)
["article_count"]=>
int(3438)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(50) "Roche to take on Abbott, Dexcom with its first CGM"
["snippet_en"]=>
string(85) "The new sensor is designed to last for 14 days but requires finger-stick calibration."
["url"]=>
string(62) "https://www.medtechdive.com/news/roche-unveil-cgm-attd/709575/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/05bcb786-fffd-44fd-846f-c1b5c132ea51"
["source"]=>
string(15) "medtechdive.com"
["publication_date"]=>
string(10) "2024-03-07"
["categories"]=>
array(1) {
[0]=>
string(11) "Competition"
}
}
[1]=>
array(7) {
["title_en"]=>
string(61) "Dundalk IT ladies side have hard fought victory over MTU Cork"
["snippet_en"]=>
string(81) "DkIT ladies team have booked their place in the Lynch Cup semi final with the win"
["url"]=>
string(114) "https://www.dundalkdemocrat.ie/news/gaa/1425749/dundalk-it-ladies-side-have-hard-fought-victory-over-mtu-cork.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/70b4a8f7-c45d-4431-9a5c-b32511a403d6"
["source"]=>
string(18) "dundalkdemocrat.ie"
["publication_date"]=>
string(10) "2024-02-17"
["categories"]=>
array(2) {
[0]=>
string(11) "Competition"
[1]=>
string(5) "Event"
}
}
[2]=>
array(7) {
["title_en"]=>
string(71) "Roche shares firmer: Roche brings new coagulation tests onto the market"
["snippet_en"]=>
string(189) "The pharmaceutical company Roche is bringing three new coagulation tests onto the market. The aim of these tests is to contribute to stroke prevention, according to a communiqué on Monday."
["url"]=>
string(120) "https://www.finanzen.ch/nachrichten/aktien/roche-aktie-fester-roche-bringt-neue-gerinnungstests-auf-den-markt-1033055624"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9d17a446-3167-452d-b06b-86755e50e156"
["source"]=>
string(11) "finanzen.ch"
["publication_date"]=>
string(10) "2024-02-12"
["categories"]=>
array(3) {
[0]=>
string(11) "Competition"
[1]=>
string(12) "Stock Market"
[2]=>
string(15) "Market Movement"
}
}
[3]=>
array(7) {
["title_en"]=>
string(82) "Roche looks back on a weak year in 2023 and only dares to make a cautious forecast"
["snippet_en"]=>
string(256) "02/01/2024 - The slump in sales in the Corona business and the strong competition from copycat products affected the pharmaceutical company Roche in the last financial year. The Swiss also had to contend with the strengthening franc. Shareholders should..."
["url"]=>
string(110) "https://www.wallstreet-online.de/nachricht/17752457-roche-blickt-schwaches-jahr-2023-wagt-vorsichtige-prognose"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5e0f71b8-17cc-4931-bf7b-0d486a581c23"
["source"]=>
string(20) "wallstreet-online.de"
["publication_date"]=>
string(10) "2024-02-01"
["categories"]=>
array(2) {
[0]=>
string(8) "Epidemic"
[1]=>
string(11) "Competition"
}
}
[4]=>
array(7) {
["title_en"]=>
string(82) "Roche looks back on a weak year in 2023 and only dares to make a cautious forecast"
["snippet_en"]=>
string(183) "BASEL (dpa-AFX) - The slump in sales in the Corona business and the strong competition from copycat products have had a negative impact on the pharmaceutical company Roche in the past"
["url"]=>
string(143) "https://www.t-online.de/finanzen/boerse/ticker/roche-blickt-auf-schwaches-jahr-2023-zurueck-und-wagt-nur-vorsichtige-prognose/0DB082000C7F9111/"
["image_url"]=>
NULL
["source"]=>
string(11) "t-online.de"
["publication_date"]=>
string(10) "2024-02-01"
["categories"]=>
array(3) {
[0]=>
string(8) "Epidemic"
[1]=>
string(11) "Competition"
[2]=>
string(25) "Business Model Resilience"
}
}
[5]=>
array(7) {
["title_en"]=>
string(28) "Roche: sales grow 1% in 2023"
["snippet_en"]=>
string(215) "The Swiss Roche managed to neutralize lower revenues related to the coronavirus and the growing competition from biosimilars and close 2022 with a slight increase of 1% in its turnover measured in constant currency."
["url"]=>
string(56) "https://www.pharmabiz.net/roche-ventas-crecen-1-en-2023/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/57264fc0-c224-4f48-9fe4-4d63fd9d9f42"
["source"]=>
string(13) "pharmabiz.net"
["publication_date"]=>
string(10) "2024-02-01"
["categories"]=>
array(2) {
[0]=>
string(8) "Epidemic"
[1]=>
string(11) "Competition"
}
}
[6]=>
array(7) {
["title_en"]=>
string(48) "Investment ideas from Alpha RHEINTAL Bank: Roche"
["snippet_en"]=>
string(97) "Roche is one of the largest pharmaceutical companies in the world and global market leader in the"
["url"]=>
string(76) "https://www.rheintaler.ch/artikel/anlageideen-der-alpha-rheintal-bank-roche/"
["image_url"]=>
NULL
["source"]=>
string(13) "rheintaler.ch"
["publication_date"]=>
string(10) "2024-01-19"
["categories"]=>
array(4) {
[0]=>
string(18) "General Investment"
[1]=>
string(19) "Investment Requests"
[2]=>
string(11) "Competition"
[3]=>
string(15) "Market Movement"
}
}
[7]=>
array(7) {
["title_en"]=>
string(77) "In race to develop obesity drugs, Roche acquires California biotech for $2.7B"
["snippet_en"]=>
string(258) "Suddenly, Eli Lilly and Co. has a new potential competitor in the lucrative market for obesity drugs. Roche AG, the health care giant based in Basel, Switzerland, says is acquiring a California-based biotech that is developing obesity drugs for $2.7 billion."
["url"]=>
string(122) "https://www.insideindianabusiness.com/articles/in-race-to-develop-obesity-drugs-roche-acquires-california-biotech-for-2-7b"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/81bd2f49-6451-418b-b562-794731bf4422"
["source"]=>
string(25) "insideindianabusiness.com"
["publication_date"]=>
string(10) "2023-12-04"
["categories"]=>
array(2) {
[0]=>
string(11) "Competition"
[1]=>
string(11) "Acquisition"
}
}
[8]=>
array(7) {
["title_en"]=>
string(32) "Health Care Roundup: Market Talk"
["snippet_en"]=>
string(116) "Find insight on Cytokinetics , Straumann, Roche and more in the latest Market Talks covering the Health Care sector."
["url"]=>
string(75) "https://www.wsj.com/finance/stocks/health-care-roundup-market-talk-be58571d"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/2220d95a-cca6-4ae9-a076-59c3270917dd"
["source"]=>
string(7) "wsj.com"
["publication_date"]=>
string(10) "2023-10-31"
["categories"]=>
array(5) {
[0]=>
string(11) "Competition"
[1]=>
string(15) "Market Movement"
[2]=>
string(16) "Customer Welfare"
[3]=>
string(24) "Access and affordability"
[4]=>
string(24) "Employee Health & Safety"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(217)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(204)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(192)
}
[3]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(156)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(153)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(148)
}
[6]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(137)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(136)
}
[8]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(111)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(105)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(102)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(97)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(92)
}
[13]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(89)
}
[14]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(86)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(69)
}
[16]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(65)
}
[17]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(64)
}
[18]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(63)
}
[19]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(49)
}
[20]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(42)
}
[21]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(40)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(40)
}
[23]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(38)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(33)
}
[25]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(33)
}
[26]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(32)
}
[27]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(32)
}
[28]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(32)
}
[29]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(32)
}
}
}
ef866-gb-roche-diagnostics-limited
ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
https://diagnostics.roche.com
Articles
3438 Articles
Category
Business Services, Not Elsewhere Classified
Description
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
The pharmaceutical company Roche is bringing three new coagulation tests onto the market. The aim of these tests is to contribute to stroke prevention, according to a communiqué on Monday.
02/01/2024 - The slump in sales in the Corona business and the strong competition from copycat products affected the pharmaceutical company Roche in the last financial year. The Swiss also had to contend with the strengthening franc. Shareholders should...
BASEL (dpa-AFX) - The slump in sales in the Corona business and the strong competition from copycat products have had a negative impact on the pharmaceutical company Roche in the past
The Swiss Roche managed to neutralize lower revenues related to the coronavirus and the growing competition from biosimilars and close 2022 with a slight increase of 1% in its turnover measured in constant currency.
Suddenly, Eli Lilly and Co. has a new potential competitor in the lucrative market for obesity drugs. Roche AG, the health care giant based in Basel, Switzerland, says is acquiring a California-based biotech that is developing obesity drugs for $2.7 billion.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
